A Tumor-Prone Gecko Is Giving Cancer Researchers a New Model

A pet-trade color morph became a cancer model

Leopard geckos are bred for color. One line, sold as lemon frost, produces a pale yellow animal that breeders prize.

It also produces tumors. The lemon frost morph develops iridophoromas, tumors of the iridophore, at a rate exceeding 80%. Iridophores are pigment cells that give reptile skin its reflective sheen. The tumors can come back after removal, and they can spread.

A study published in BMC Biology on July 15, 2026 by Hastings, Gamble, Ossiboff and colleagues sequenced the genomes of these tumors. The University of Nottingham announced the work through EurekAlert.

What the researchers did

They performed high-coverage whole-genome sequencing on matched tumor and non-tumor samples from three lemon frost geckos. Matched means each tumor was compared with normal tissue from the same animal, so inherited differences do not get mistaken for tumor changes.

Four findings stand out in their report:

• A shared missense mutation in TBP, the TATA-box binding protein, which helps switch genes on. A missense mutation swaps one amino acid for another.
• A recurrent gene fusion joining IARS1 and RNF213, present in every tumor sample.
• Copy-number neutral loss of heterozygosity in three genes with known cancer roles: MAP3K13, TENM4, and an OR2AT4-like gene. That means one parent's copy was replaced by a duplicate of the other, without changing the total amount of DNA.
• Copy-number gains in four regions of the genome.

Pathway analysis pointed to disruption in actin filament organization. Actin filaments give a cell its shape and let it crawl, which is why that pathway keeps appearing in studies of how tumors spread.

Why an animal with too much cancer is useful

This is comparative oncology: looking at cancer across species instead of only in humans and laboratory mice.

The study's authors make the logic explicit. Animals with naturally very high or very low cancer rates can reveal mechanisms of spread and of resistance that ordinary models hide. A deviation in either direction is a clue, because something in that animal's biology is pushing hard one way.

The lemon frost line has a particular advantage. The cancer-prone trait was created by breeding, it is tied to a visible color, and it is inherited in a known way. Researchers can therefore study tumor formation from the beginning rather than meeting it after diagnosis.

The human cancer this is nearest to

Iridophoromas are not melanoma. They arise from a pigment cell type that mammals do not have.

Still, melanoma is the human comparison worth understanding, because it too starts in a pigment cell. Melanocytes make melanin, and melanoma is what happens when they become malignant.

NCI notes that more than half of melanomas arise in skin that looked normal, not in an existing mole. When a mole does change, the early warning signs are darker or uneven color, itching, growth, or new spots appearing around it. Ulceration and bleeding are later signs.

When to get a skin spot checked

NCI describes the ABCDE checklist that clinicians and the public both use for pigmented lesions:

• Asymmetry: one half does not match the other.
• Border: edges are ragged, notched, or blurred.
• Color: more than one shade, or an uneven mix.
• Diameter: larger than 6 mm, roughly a pencil eraser.
• Evolution: any change over weeks or months.

Evolution is the one that matters most in practice. A spot that is changing deserves a look even if it passes the other four tests. So does any spot that itches, bleeds, or will not heal.

NCI adds a practical instruction for clinicians: a suspicious lesion should be biopsied, preferably by local excision, and should never be shaved off or cauterized. If you are offered a quick cosmetic removal of a spot that worries you, ask whether it is going to a pathologist.

The human numbers, for scale

About 112,000 new melanoma diagnoses and about 8,510 deaths are projected for the United States in 2026 by the American Cancer Society, with SEER republishing them. SEER's measured five-year relative survival across all stages was 94.7% for 2016 to 2022, and 77% of cases are found while still confined to the original site.

Those figures describe a large group over past years of care, not any one person. They are high mainly because melanoma is often caught early, and the picture changes sharply by stage. Our page on melanoma sets out what stage means here.

What this does not mean

• Gecko iridophoromas are not human melanoma, and findings in one do not transfer automatically to the other.
• Three animals is a small sample. These are candidate genomic changes, not established drivers.
• Nothing in this study is a treatment, a test, or a screening method for people.
• The gene changes named here have not been shown to cause human cancer in this pattern.
• Reptile owners should not read risk for other species or morphs from this one breeding line.

The open questions

The researchers frame the value of the model as a set of questions it can now be used to ask. Which changes start a tumor, and which appear later? Which ones track with recurrence or spread? Are any of the pathways conserved across vertebrates, and therefore worth chasing in humans?

Answering those is the work ahead, and it is the reason to report this as a research model rather than as a finding about people.

Sources

• Hastings BT, Gamble T, Ossiboff RJ, et al. Dissecting cancer in a non-mammalian model: genomic insights from lemon frost geckos. BMC Biology 2026;24(1)
• EurekAlert / University of Nottingham: Scientists uncover genetic clues from a tumour-prone reptile that could advance cancer research
• NCI PDQ: Melanoma Treatment (Health Professional Version)
• SEER Cancer Stat Facts: Melanoma of the Skin

How this page was made

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.